Key points from article :
Astronauts and ageing seniors face similar health challenges related to muscle and bone weakening, prompting research into mitigating these issues.
The University of Central Florida is collaborating with biotech company Vaxxinity to develop vaccines targeting muscle and bone atrophy.
The research aims to assess the effects of Vaxxinity's immunotherapies on proteins affecting bone and muscle growth, potentially aiding both space travelers and ageing populations on Earth.
Human clinical trials for the vaccines could commence by 2025, pending successful research outcomes.
The initiative aligns with Florida's interest in healthy ageing due to its large senior population and tourism-driven economy.
